Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

RMD open

Showing results (331-340 of 2,089) with videos related to

Pageof 209
Sort By:
RMD Open|February 9, 2023
Prognosis of spontaneous pneumomediastinum occurring in dermatomyositis or polymyositis patients with interstitial lung disease according to antimelanoma differentiation-associated gene 5 antibody status: a retrospective cohort studyKazuya Abe, Shunsuke Furuta, Yoshihisa Kobayashi, et al.
RMD Open|February 9, 2023
Lipid management in systemic lupus erythematosus according to risk classifiers suggested by the European Society of Cardiology and disease-related risk factors reported by the EULAR recommendationsGeorge C Drosos, George Konstantonis, Petros P Sfikakis, et al.
RMD Open|November 28, 2025
Long-term outcomes of JIA-associated uveitis: a systematic review and meta-analysisLaura Scagnellato, Giacomo Cozzi, Mariagrazia Lorenzin, et al.
RMD Open|November 11, 2025
Diagnostic performance and reliability of robotic ultrasonography and artificial intelligence-driven synovitis assessment in rheumatoid arthritis: results from the Controlled ARTHUR TrialMads Ammitzbøll-Danielsen, Mikkel Østergaard, Lydia Tamm, et al.
RMD Open|January 6, 2026
Mesenchymal stromal cells ameliorate systemic sclerosis-interstitial lung disease via PD-1/PD-L1 signalling axisYuxuan Chen, Huimin Zhu, Yue Zhang, et al.
RMD Open|January 6, 2026
Sjögren's disease metabolome reveals biomarker signatures to characterise patients and assess disease activityMadeleine Suffiotti, Lukas Tanner, Lukasz Kozera, et al.
RMD Open|January 22, 2026
Incidence rate and risk factors of arrhythmias in patients with psoriatic arthritisAbdulrahman Y Almansouri, Jiayi Li, Laura Bumbulis, et al.
RMD Open|December 31, 2025
Heterogeneity of antiphospholipid antibody profiles in a clinical cohort and association with distinct clinical featuresZhongjun Shen, Shuo Yang, Shangjia Jin, et al.
RMD Open|December 23, 2025
Global social media use among rheumatology professionals: the EULAR SoMeR Study Group surveyLatika Gupta, Manali Sarkar, Jeffrey Sparks, et al.
RMD Open|November 5, 2025
Long-term safety and efficacy of upadacitinib in Japanese patients with rheumatoid arthritis and inadequate response to conventional synthetic disease-modifying antirheumatic drugs: 5-year results from the SELECT-SUNRISE randomised controlled trialHideto Kameda, Tsutomu Takeuchi, Kunihiro Yamaoka, et al.
Pageof 209

Showing results (331-340 of 2,089) with videos related to

Sort By:
Pageof 209
RMD Open|February 9, 2023
Prognosis of spontaneous pneumomediastinum occurring in dermatomyositis or polymyositis patients with interstitial lung disease according to antimelanoma differentiation-associated gene 5 antibody status: a retrospective cohort studyKazuya Abe, Shunsuke Furuta, Yoshihisa Kobayashi, et al.
RMD Open|February 9, 2023
Lipid management in systemic lupus erythematosus according to risk classifiers suggested by the European Society of Cardiology and disease-related risk factors reported by the EULAR recommendationsGeorge C Drosos, George Konstantonis, Petros P Sfikakis, et al.
RMD Open|November 28, 2025
Long-term outcomes of JIA-associated uveitis: a systematic review and meta-analysisLaura Scagnellato, Giacomo Cozzi, Mariagrazia Lorenzin, et al.
RMD Open|November 11, 2025
Diagnostic performance and reliability of robotic ultrasonography and artificial intelligence-driven synovitis assessment in rheumatoid arthritis: results from the Controlled ARTHUR TrialMads Ammitzbøll-Danielsen, Mikkel Østergaard, Lydia Tamm, et al.
RMD Open|January 6, 2026
Mesenchymal stromal cells ameliorate systemic sclerosis-interstitial lung disease via PD-1/PD-L1 signalling axisYuxuan Chen, Huimin Zhu, Yue Zhang, et al.
RMD Open|January 6, 2026
Sjögren's disease metabolome reveals biomarker signatures to characterise patients and assess disease activityMadeleine Suffiotti, Lukas Tanner, Lukasz Kozera, et al.
RMD Open|January 22, 2026
Incidence rate and risk factors of arrhythmias in patients with psoriatic arthritisAbdulrahman Y Almansouri, Jiayi Li, Laura Bumbulis, et al.
RMD Open|December 31, 2025
Heterogeneity of antiphospholipid antibody profiles in a clinical cohort and association with distinct clinical featuresZhongjun Shen, Shuo Yang, Shangjia Jin, et al.
RMD Open|December 23, 2025
Global social media use among rheumatology professionals: the EULAR SoMeR Study Group surveyLatika Gupta, Manali Sarkar, Jeffrey Sparks, et al.
RMD Open|November 5, 2025
Long-term safety and efficacy of upadacitinib in Japanese patients with rheumatoid arthritis and inadequate response to conventional synthetic disease-modifying antirheumatic drugs: 5-year results from the SELECT-SUNRISE randomised controlled trialHideto Kameda, Tsutomu Takeuchi, Kunihiro Yamaoka, et al.
Pageof 209